Wednesday, September 16, 2020 9:53:55 AM
$KODK Current Report Filing (8-k)
September 16 2020 - 09:13AM
Edgar (US Regulatory)
Alert
Print
Share On Facebook
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
________________
Form 8-K
________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 15, 2020
EASTMAN KODAK COMPANY
(Exact name of registrant as specified in its charter)
NEW JERSEY
(State or other jurisdiction of incorporation)
1-87
(Commission File Number)
16-0417150
(IRS Employer
Identification No.)
343 State Street
Rochester, NY 14650
(Address of principal executive offices with zip code)
(585) 724-4000
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
?
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
?
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
?
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
?
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common stock, par value $0.01 per share
KODK
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§?230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§?240.12b-2 of this chapter).
Emerging growth company. ?
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ?
Item 7.01Regulation FD Disclosure
On August 7, 2020, Eastman Kodak Company (the “Company”) announced that it had formed a special committee (the “Special Committee”) to oversee an internal review of recent activity by the Company and related parties in connection with the announcement of a potential loan by the U.S. International Development Finance Corporation to support the launch of Kodak Pharmaceuticals, and that the Special Committee had retained Akin Gump Strauss Hauer & Feld LLP (“Akin Gump”) to conduct this review. On September 15, 2020, the Special Committee issued a press release announcing that it completed this review and that Akin Gump had delivered a report to the Special Committee in connection with this review (the “Report”). On September 15, 2020, the Company issued a press release confirming its receipt and acceptance of the findings and recommendations of the Report.
A copy of the Press Release issued by the Special Committee is furnished as Exhibit 99.1 hereto. A copy of the Press Release issued by the Company is furnished as Exhibit 99.2 hereto. A copy of the Report is furnished as Exhibit 99.3 hereto. This Item 7.01 and Exhibits 99.1, 99.2 and 99.3 (the “Furnished Information”) are being furnished and shall not be deemed “filed” for any purpose. The Furnished Information shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference to the Furnished Information in such filing.
Item 9.01Financial Statements and Exhibits
(d)
Exhibits (all furnished and not filed)
(99.1)
Press release issued on September 15, 2020 by the Special Committee
(99.2)
Press release issued on September 15, 2020 by the Company
(99.3)
Report delivered by Akin Gump
1
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
EASTMAN KODAK COMPANY
By:
/s/Roger W. Byrd
Name: Roger W. Byrd
Title: General Counsel, Secretary
and Senior Vice President
Date: September 16, 2020
2
September 16 2020 - 09:13AM
Edgar (US Regulatory)
Alert
Share On Facebook
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
________________
Form 8-K
________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 15, 2020
EASTMAN KODAK COMPANY
(Exact name of registrant as specified in its charter)
NEW JERSEY
(State or other jurisdiction of incorporation)
1-87
(Commission File Number)
16-0417150
(IRS Employer
Identification No.)
343 State Street
Rochester, NY 14650
(Address of principal executive offices with zip code)
(585) 724-4000
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
?
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
?
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
?
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
?
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common stock, par value $0.01 per share
KODK
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§?230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§?240.12b-2 of this chapter).
Emerging growth company. ?
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ?
Item 7.01Regulation FD Disclosure
On August 7, 2020, Eastman Kodak Company (the “Company”) announced that it had formed a special committee (the “Special Committee”) to oversee an internal review of recent activity by the Company and related parties in connection with the announcement of a potential loan by the U.S. International Development Finance Corporation to support the launch of Kodak Pharmaceuticals, and that the Special Committee had retained Akin Gump Strauss Hauer & Feld LLP (“Akin Gump”) to conduct this review. On September 15, 2020, the Special Committee issued a press release announcing that it completed this review and that Akin Gump had delivered a report to the Special Committee in connection with this review (the “Report”). On September 15, 2020, the Company issued a press release confirming its receipt and acceptance of the findings and recommendations of the Report.
A copy of the Press Release issued by the Special Committee is furnished as Exhibit 99.1 hereto. A copy of the Press Release issued by the Company is furnished as Exhibit 99.2 hereto. A copy of the Report is furnished as Exhibit 99.3 hereto. This Item 7.01 and Exhibits 99.1, 99.2 and 99.3 (the “Furnished Information”) are being furnished and shall not be deemed “filed” for any purpose. The Furnished Information shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference to the Furnished Information in such filing.
Item 9.01Financial Statements and Exhibits
(d)
Exhibits (all furnished and not filed)
(99.1)
Press release issued on September 15, 2020 by the Special Committee
(99.2)
Press release issued on September 15, 2020 by the Company
(99.3)
Report delivered by Akin Gump
1
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
EASTMAN KODAK COMPANY
By:
/s/Roger W. Byrd
Name: Roger W. Byrd
Title: General Counsel, Secretary
and Senior Vice President
Date: September 16, 2020
2
Recent KODK News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 08:32:13 PM
- Hubble Connected Partners with Kodak to Launch New Family Technology Ecosystem Across Baby, Kids, and Pet Categories • PR Newswire (US) • 05/12/2026 05:07:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 08:21:10 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2026 08:21:02 PM
- Kodak Reports First-Quarter 2026 Financial Results • Business Wire • 05/07/2026 08:15:00 PM
- Eastman Kodak Company First-Quarter 2026 Earnings Conference Call • Business Wire • 04/30/2026 03:42:00 PM
- Kodak Expands Motion Picture Portfolio with KODAK VERITA 200D Color Negative Film • Business Wire • 04/13/2026 05:35:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/09/2026 12:03:55 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/09/2026 12:01:44 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/09/2026 12:00:43 PM
- Ateios Systems and Kodak Expand RaiCore™ Platform to Major Battery Chemistries and Earn PFAS-Free Verification • Business Wire • 03/23/2026 02:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/12/2026 08:21:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/12/2026 08:18:33 PM
- Kodak Reports Fourth-Quarter and Full-Year 2025 Financial Results • Business Wire • 03/12/2026 08:15:00 PM
- Eastman Kodak Company Fourth-Quarter and Full-Year 2025 Earnings Conference Call • Business Wire • 03/05/2026 04:13:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2026 09:31:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2026 10:00:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 02:15:33 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/19/2026 09:15:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2026 09:32:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/17/2026 09:31:20 PM
- Kodak Expands Pharmaceuticals Portfolio with Four Regulated Products • Business Wire • 01/26/2026 06:00:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 01/21/2026 05:30:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/16/2026 09:32:05 PM
